Additional European Equity News

AstraZeneca (AZN LN) - Tagrisso with the addition of chemotherapy approved in the EU as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer. (AstraZeneca)

Atos (ATO FP) - Secured short-term funding via a syndication agreement, under the EUR 1.5bln term loan of the Co.. Restructuring operations to be implemented in H2. (Newswires)

Saab (SAAB SS) - Co's new navigation system has been approved for use within the Panama Canal. (Newswires)

Shell (SHEL LN) - Co. expects a non-cash post tax impairment of USD 1.5-2.0bln in Q2. Q2: Upstream production seen at 1720-1820k/BOEPD; Integrated gas production 940-980k/BOEPD. (Shell)

05 Jul 2024 - 07:10- EquitiesResearch Sheet- Source: Newsquawk

AstraZeneca PLCPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals (Group)PharmaceuticalsAtoSEuropean Equity NewsEquitiesEuropeUnited KingdomAZN.LNATO.FPFTSE 100 IndexATOSHELIntegrated Oil & GasGas Utilities (Group)Gas UtilitiesEnergy (Group)Atmos Energy CorpShell PLCUtilities (Group)Oil, Gas & Consumable FuelsS&P 500 IndexHighlightedResearch SheetAsian SessionEU SessionResearch SheetHighlightedAsian SessionEU SessionUSDEURAZNUnited StatesNASDAQ 100 Index

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: